RAP-041 mediated modulation of intratumoral immune cell subpopulations in vivo and effect of combination treatment with anti-PD1 monoclonal antibody
Research Grant
Administered By
Medicine, Medical Oncology
Awarded By
Acceleron Pharma
Start Date
September 27, 2016
End Date
September 26, 2018
Administered By
Medicine, Medical Oncology
Awarded By
Acceleron Pharma
Start Date
September 27, 2016
End Date
September 26, 2018